Company page

Shattuck Labs, Inc.

Shattuck Labs, Inc. is a public company traded under the ticker STTK in the American market, with a market capitalization of approximately $447.3 million. The company focuses on developing innovative therapies for cancer and autoimmune diseases. Shattuck Labs aims to advance its proprietary technology to improve treatment outcomes for patients.